Regorafenib in Metastatic Colorectal Cancer

Clinical trial NCT02466009 · COMPLETED

Trial details

NCT number: NCT02466009
Sponsor: University of Rochester
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer

Start date: 2015-03-01
Primary completion: 2019-07-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.